0001493152-17-004512.txt : 20170428
0001493152-17-004512.hdr.sgml : 20170428
20170428131841
ACCESSION NUMBER: 0001493152-17-004512
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170427
FILED AS OF DATE: 20170428
DATE AS OF CHANGE: 20170428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
BUSINESS PHONE: 2153450919
MAIL ADDRESS:
STREET 1: 621 N. SHADY RETREAT ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18901
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karkus Ted William
CENTRAL INDEX KEY: 0001457896
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 17793655
MAIL ADDRESS:
STREET 1: 188 HEWLETT NECK ROAD
CITY: WOODMERE
STATE: NY
ZIP: 11598
4
1
form4.xml
X0306
4
2017-04-27
0
0000868278
ProPhase Labs, Inc.
PRPH
0001457896
Karkus Ted William
621 N. SHADY RETREAT ROAD
DOYLESTOWN
PA
18901
1
1
1
0
CEO & Chairman
Option (right to buy)
2.00
2017-04-27
4
A
0
600000
0.00
A
2024-04-27
Common Stock
600000
600000
D
The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in four equal annual installments beginning April 26, 2018, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 27, 2017.
/s/ Ted Karkus
2017-04-28